Summit Street Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.9M | Sell |
72,040
-1,943
| -3% | -$721K | 3.91% | 6 |
|
|
2026
Q1 | $21.7M | Buy |
73,983
+11,087
| +18% | +$3.64M | 3.06% | 16 |
|
|
2025
Q4 | $22M | Buy |
62,896
+9,704
| +18% | +$3.28M | 3.47% | 16 |
|
|
2025
Q3 | $17.2M | Buy |
53,192
+19,282
| +57% | +$6M | 2.36% | 25 |
|
|
2025
Q2 | $13.2M | Sell |
33,910
-6,663
| -16% | -$2.68M | 2.18% | 27 |
|
|
2025
Q1 | $17.6M | Buy |
40,573
+1,154
| +3% | +$463K | 2.94% | 23 |
|
|
2024
Q4 | $14.5M | Buy |
39,419
+22,478
| +133% | +$9.41M | 2.28% | 27 |
|
|
2024
Q3 | $8.81M | Hold |
16,941
| – | – | 3.15% | 17 |
|
|
2024
Q2 | $9.18M | Buy |
16,941
+1,050
| +7% | +$555K | 3.35% | 12 |
|
|
2024
Q1 | $8.24M | Buy |
15,891
+2,426
| +18% | +$1.21M | 3.16% | 14 |
|
|
2023
Q4 | $6.35M | Hold |
13,465
| – | – | 2.69% | 23 |
|
|
2023
Q3 | $5.86M | Hold |
13,465
| – | – | 2.62% | 24 |
|
|
2023
Q2 | $5.98M | Hold |
13,465
| – | – | 2.82% | 22 |
|
|
2023
Q1 | $6.19M | Hold |
13,465
| – | – | 3.29% | 14 |
|
|
2022
Q4 | $6.91M | Hold |
13,465
| – | – | 4.36% | 5 |
|
|
2022
Q3 | $6.12M | Hold |
13,465
| – | – | 4.24% | 6 |
|
|
2022
Q2 | $6.5M | Sell |
13,465
-2,770
| -17% | -$1.37M | 4.26% | 4 |
|
|
2022
Q1 | $7.97M | Hold |
16,235
| – | – | 4.82% | 2 |
|
|
2021
Q4 | $7.53M | Hold |
16,235
| – | – | 4.69% | 3 |
|
|
2021
Q3 | $6.05M | Hold |
16,235
| – | – | 4.02% | 4 |
|
|
2021
Q2 | $6.2M | Hold |
16,235
| – | – | 3.97% | 4 |
|
|
2021
Q1 | $5.83M | Buy |
16,235
+2,156
| +15% | +$693K | 3.78% | 5 |
|
|
2020
Q4 | $4.52M | Buy |
14,079
+779
| +6% | +$239K | 3.38% | 13 |
|
|
2020
Q3 | $3.57M | Buy |
13,300
+4,797
| +56% | +$1.29M | 3.16% | 12 |
|
|
2020
Q2 | $2.24M | Buy |
+8,503
| New | +$2.27M | 1.87% | 28 |
|
|
2018
Q1 | – | Sell |
-18,324
| Closed | -$4.12M | – | 34 |
|
|
2017
Q4 | $4.12M | Hold |
18,324
| – | – | 4.07% | 3 |
|
|
2017
Q3 | $3.48M | Sell |
18,324
-2,500
| -12% | -$476K | 3.97% | 9 |
|
|
2017
Q2 | $3.92M | Hold |
20,824
| – | – | 4.51% | 3 |
|
|
2017
Q1 | $3.44M | Hold |
20,824
| – | – | 3.77% | 5 |
|
|
2016
Q4 | $2.99M | Hold |
20,824
| – | – | 3.32% | 11 |
|
|
2016
Q3 | $2.61M | Buy |
20,824
+4,490
| +27% | +$580K | 2.8% | 18 |
|
|
2016
Q2 | $2.15M | Hold |
16,334
| – | – | 2.39% | 23 |
|
|
2016
Q1 | $2.27M | Buy |
+16,334
| New | +$2.18M | 2.36% | 24 |
|
|
2015
Q3 | – | Sell |
-19,831
| Closed | -$3.25M | – | 36 |
|
|
2015
Q2 | $3.25M | Hold |
19,831
| – | – | 3.13% | 9 |
|
|
2015
Q1 | $3.06M | Sell |
19,831
-12,417
| -39% | -$1.77M | 2.74% | 15 |
|
|
2014
Q4 | $4.05M | Buy |
+32,248
| New | +$3.98M | 3.98% | 3 |
|
Other funds holding ELV
Summit Street Capital Management's ELV Position: Q2 2026 in Review
Summit Street Capital Management reduced its Elevance Health (ELV) stake by 2.6% in Q2 2026, selling an estimated $721K and leaving 72,040 shares worth $27.9M. The position accounts for 3.91% of the portfolio, ranked #6.
Summit Street Capital Management first reported a position in ELV in Q4 2014 and has held it in 36 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Summit Street Capital Management held 72,040 shares of Elevance Health worth $27.9M as of Q2 2026.
- Summit Street Capital Management sold 1,943 Elevance Health shares in Q2 2026, an estimated $721K.
- Elevance Health made up 3.91% of Summit Street Capital Management's portfolio in Q2 2026, its #6 holding.
- Summit Street Capital Management first reported a position in Elevance Health in Q4 2014 and has held it in 36 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Summit Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.